Cyclophilin A may contribute to the inflammatory processes in rheumatoid arthritis through induction of matrix degrading enzymes and inflammatory cytokines from macrophages

被引:167
作者
Kim, H
Kim, WJ
Jeon, ST
Koh, EM
Cha, HS
Ahn, KS
Lee, WH [1 ]
机构
[1] Kyungpook Natl Univ, Dept Genet, Taegu 702701, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Rheumatol, Seoul, South Korea
关键词
cyclophilin A; matrix metalloproteinase (MMP)-9; rheumatoid arthritis;
D O I
10.1016/j.clim.2005.05.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Cyclophilin A (CypA) levels increase in the sera and synovial fluids of rheumatoid arthritis (RA) patients, but the cell types expressing CypA and the function of CypA in the pathogenesis of RA are not known yet. Immunohistochemistry analyses revealed high level CypA staining in the macrophages in the lining layers of human RA and osteoarthritis synovium. Low level CypA staining was also detected ill endothelial cells, lymphocytes, and smooth muscle cells in RA synovium. Further investigation of the CypA function using monocyte/macrophage cell lines revealed that CypA induced expression of cytokine/chemokines such as TNF-alpha, IL-8, MCP-1, and IL-1 beta and matrix metalloproteinase (MMP)-9 through a pathway that is dependent oil NF kappa B activation. Furthermore, MMP-9 staining pattern overlapped with that of CypA in both RA and OA synovium. Our data suggest that CypA may stimulate macrophages to degrade joint cartilage via MMP-9 expression and promote inflammation via pro-inflammatory cytokine secretion. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:217 / 224
页数:8
相关论文
共 33 条
[1]
Disruption of 3-phosphoinositide-dependent kinase 1 (PDK1) signaling by the anti-tumorigenic and anti-proliferative agent N-α-tosyl-1-phenylalanyl chloromethyl ketone [J].
Ballif, BA ;
Shimamura, A ;
Pae, E ;
Blenis, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (15) :12466-12475
[2]
Presence of cyclophilin a in synovial fluids of patients with rheumatoid arthritis [J].
Billich, A ;
Winkler, G ;
Aschauer, H ;
Rot, A ;
Peichl, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (05) :975-980
[3]
Bresnihan B, 1999, J RHEUMATOL, V26, P717
[4]
Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions [J].
Coppinger, JA ;
Cagney, G ;
Toomey, S ;
Kislinger, T ;
Belton, O ;
McRedmond, JP ;
Cahill, DJ ;
Emili, A ;
Fitzgerald, DJ ;
Maguire, PB .
BLOOD, 2004, 103 (06) :2096-2104
[5]
Cunnane Gaye, 1998, Archivum Immunologiae et Therapiae Experimentalis, V46, P1
[6]
Fernandes JC, 2002, BIORHEOLOGY, V39, P237
[7]
PEPTIDYLPROLINE CIS-TRANS-ISOMERASES - IMMUNOPHILINS [J].
GALAT, A .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 216 (03) :689-707
[8]
Giannelli G, 2004, CLIN EXP RHEUMATOL, V22, P335
[9]
Markedly elevated serum MMP-9 (gelatinase B) levels in rheumatoid arthritis: A potentially useful laboratory marker [J].
Gruber, BL ;
Sorbi, D ;
French, DL ;
Marchese, RRJ ;
Nuovo, GJ ;
Kew, RR ;
Arbeit, LA .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1996, 78 (02) :161-171
[10]
Ethyl pyruvate inhibits nuclear factor-κB-dependent signaling by directly targeting p65 [J].
Han, YS ;
Englert, JA ;
Yang, RK ;
Delude, RL ;
Fink, MP .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 312 (03) :1097-1105